Skip to main content

Table 4 Immunocytochemical scores for MMP-9, MMP-2 and VEGF-A in B-cell lymphomas, T-cell lymphomas and control lymph nodes expressed as mean (min-max)

From: The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study

 

MMP-9

MMP-2

VEGF-A

HG B-cell lymphomas

22.1% (13–35)

16.9% (3–22)

17.3% (11–23)

LG B-cell lymphomas

15.7% (11–27)

4.2% (2–7)

13.8% (12–17)

HG T-cell lymphomas

79.8% (56–89)

38.4% (29–45)

44.7% (38–48)

LG T-cell lymphomas

41.3% (25–63)

30.2 (26–33)

30.2% (18–37)

Control lymph nodes

4.2% (1–7)

0.8% (0–2)

0.8% (0–2)